SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
In explaining the rationale behind the study, Tang and colleagues pointed out that despite the lack of level 1 evidence, MDT ...
A new generation of engineered immune cell destroys cancer cells in mice 1 as effectively as conventional CAR-T-cell ...
Live Science on MSN
New triple-drug treatment stops pancreatic cancer in its tracks, a mouse study finds
By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...
The Daily Galaxy on MSN
Scientists cure pancreatic cancer using new therapy that eliminated tumors with no major side effects
Pancreatic cancer remains one of the deadliest cancers known, but two independent experimental therapies have now ...
New research suggests the targeted radiation treatment may reduce long-term side effects while maintaining strong cancer ...
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Experts discuss the challenges of integrating new cancer therapies, addressing multidisciplinary care, evolving guidelines, and the financial burden on patients.
QIMR Berghofer scientists have discovered a cancer-fighting RNA molecule that could hold the key to a new way of treating the ...
The announcement was made during a ceremony at C Spire’s corporate headquarters in Ridgeland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results